EP3405212
Bóluefni gegn krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.1.2017EP published:
8.7.2020EP application number:
17702951.9
EP translation filed:
24.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
15.1.2037Expiry date:
15.1.2022
Title:
CANCER VACCINES
Timeline
Today
16.1.2017EP application
8.7.2020EP Publication
24.8.2020Translation submitted
15.9.2020Registration published
15.1.2022Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York, NY 10017, US
Inventor
Name:
BINDER, Joseph JohnAddress:
San Diego, CA 92128, US
Name:
CHO, Helen KimAddress:
San Diego, CA 92130, US
Name:
COCKLE, Paul JasonAddress:
San Anselmo, CA 94960, US
Name:
FALCONER, Derek JohnAddress:
San Diego, CA 92130, US
Name:
GURU, SiradanahalliAddress:
San Diego, CA 92130, US
Name:
JOOSS, Karin UteAddress:
San Diego, CA 92106, US
Name:
MARTINIC, Marianne Marcela AndreaAddress:
La Jolla, CA 92037, US
Name:
WILLS, Kenneth NelsonAddress:
Carlsbad, CA 92009, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662280636 PDate:
19.1.2016Country:
US
Number:
201662419190 PDate:
8.11.2016Country:
US
Classification
Categories:
A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.11.2020
Expires: 15.1.2022
Payer: Árnason Faktor ehf.